Raquel Buj

6PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 30, 2026
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.

|May 27, 2026
αKG-mediated carnitine synthesis drives DNA repair via histone acetylation.

|Jun 13, 2025
ATR promotes mTORC1 activity via de novo cholesterol synthesis.

Naveen Kumar Tangudu, Alexandra N Grumet, Richard Fang

|Feb 20, 2025
Zinc availability in the tumor microenvironment dictates anti-PD1 response in CDKN2A Low tumors via increased macrophage phagocytosis.

Raquel Buj, Aidan R Cole, Jeff Danielson

|Apr 16, 2024
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression.

Naveen Kumar Tangudu, Raquel Buj, Hui Wang

|Apr 30, 2021
Loss of p16: A Bouncer of the Immunological Surveillance?

Kelly E Leon, Naveen Kumar Tangudu, Katherine M Aird

Pageof 1

Frequent Collaborators

4 joint publications

Katherine M Aird

4 joint publications

Nathaniel W Snyder

3 joint publications

Aidan R Cole

3 joint publications

Adam Chatoff